Biomarin Pharma Inc convertible/ shares owned by Loomis, Sayles and
Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Loomis, Sayles and
from 13F filings
Historical chart of Loomis, Sayles and investment in Biomarin Pharma Inc convertible/
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharma Inc convertible/ held by Loomis, Sayles and consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Loomis, Sayles and
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $41M | 469k | 87.34 |
| 2023-09-30 | $51M | 578k | 88.48 |
| 2023-06-30 | $51M | 588k | 86.68 |
| 2023-03-31 | $60M | 612k | 97.24 |
| 2022-12-31 | $78M | 756k | 103.49 |
| 2022-09-30 | $69M | 811k | 84.77 |
| 2022-06-30 | $68M | 823k | 82.87 |
| 2022-03-31 | $70M | 902k | 77.10 |
| 2021-12-31 | $80M | 906k | 88.35 |
| 2021-09-30 | $62M | 795k | 77.29 |
| 2021-06-30 | $64M | 765k | 83.44 |
| 2021-03-31 | $51M | 678k | 75.51 |
| 2020-12-31 | $56M | 634k | 87.69 |
| 2020-09-30 | $47M | 619k | 76.08 |
| 2020-06-30 | $118M | 959k | 123.34 |
| 2020-03-31 | $122M | 1.4M | 84.50 |
| 2019-12-31 | $132M | 1.6M | 84.55 |
| 2019-09-30 | $65M | 963k | 67.40 |
| 2019-06-30 | $122M | 943k | 129.42 |
| 2019-03-31 | $117M | 915k | 127.55 |
| 2018-12-31 | $77M | 899k | 85.15 |
| 2018-09-30 | $121M | 907k | 132.87 |
| 2018-06-30 | $116M | 921k | 125.94 |
| 2018-03-31 | $90M | 766k | 117.03 |
| 2017-12-31 | $70M | 565k | 124.20 |
| 2017-09-30 | $45M | 353k | 126.30 |
Top funds holding Biomarin Pharma Inc convertible/
View all funds holding Biomarin Pharma Inc convertible/